SUMMARY Although clinical studies indicate that patients with idiopathic dilated congestive cardiomyopathy who develop electrocardiographic or angiographic signs of left ventricular (LV) hypertrophy may survive longer, there is little morphologic evidence for such anatomic favorable or unfavorable prognostic groups. We studied 30 autopsied patients who died of dilated cardiomyopathy; of these, 15 died within 1 year of the first symptom of their disease (short-term survivors) and 15 patients died 1-14 years after initial symptoms (long-term survivors). There were no significant differences in sex, race, clinical presentation or cause of death between the groups, but there were significant morphologic differences. In the short-term survivors, average heart weight was S40 g and LV wall thickness was 1.0 cm, whereas in the long-term survivors, the average heart weight was 759 g and LV wall thickness was 1.3 cm (p < 0.001). LV cavity dilatation as measured by maximal transverse diameter from the postmortem angiograms did not differ between the two groups. These patients were compared with 10 autopsied patients with normal hearts and no clinical cardiac disease and 10 autopsied patients with volume overload secondary to valvular regurgitation. An LV hypertrophy/dilatation index (thickness/diameter) was 0.17 i 0.07 for the short-term survivors, 0.21 i 0.07 for the long-term survivors, 0.38 ± 0.07 for volume overload patients, and 0.48 :L 0.19 for normal subjects (F = 20.24, p < 0.001). Thus, in patients with hypertrophy due to volume overload, wall thickening increased with dilatation, returning the ratio of wall thickness to cavity size toward normal. In contrast, among the idiopathic congestive cardiomyopathies, dilatation was disproportionate to hypertrophy and the difference was most marked for short-term survivors. 
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Materials and Methods
Patients from the autopsy files of The Johns Hopkins Hospital were included in this study if (1) they had a clinical history of congestive heart failure; (2) there was evidence of biventricular dilatation; (3) the heart valves and coronary arteries were normal; and (4) both the gross specimen and postmortem angiograms were available for study. Patients were excluded if (1) they had a history of systemic hypertension; (2) there was pathologic evidence of a restrictive, infiltrative or hypertrophic cardiomyopathy; (3) they had congenital anomalies; and (4) there was histologic evidence of active myocarditis. The autopsy files for the past 15 years were reviewed and 30 cases fulfilled the criteria for inclusion. As controls, we studied 10 normal hearts from adults who had neither clinical nor pathologic evidence of cardiovascular disease and 10 adult hearts with long-standing volume overload due to pure aortic regurgitation (five hearts) or pure mitral regurgitation (five hearts). These 20 comparison hearts met the stated criteria. They were prepared postmortem, as the study hearts were, with coronary arteriography and formalin fixation in distention. Of these 10 patients, one was in class III-IV heart failure; the others had compensated volume overload at the time of death and died either of noncardiac problems or at surgery.
All patients' clinical records were studied. The medical history, clinical course, chest radiograph, ECG, and laboratory data were reviewed. The duration of symptoms was defined as the interval between the patient's first reported symptom and death.
Patients with less than 1 year of symptoms were classified as short-term survivors; those with more than 1 year of symptoms were classified as long-term survivors.
At autopsy, the hearts were weighed, prepared by postmortem angiography using injection of a gelatinpigment-barium mass at pressures of 100-150 mm Hg controlled by manometer, and then fixed in formalin in a distended state at pressures of 40-50 mm Hg. Radiographs were prepared of the intact heart and its transverse sections. The hearts were examined grossly and histologically for the presence of restrictive, infiltrative, or hypertrophic disease. The postmortem angiograms were studied to determine the presence of coronary artery disease. The hearts were serially sliced and the slice at the level of the papillary muscle was used to measure anterior, lateral, septal and posterior left ventricular wall thickness, which was averaged to give an average left ventricular wall thickness for each heart. Papillary muscles, trabeculae carni and epicardial fat were not included in these measurements. The same heart slice was used to determine a maximal left ventricular cavity size. Left ventricular volumes were estimated by determining the volume of water necessary to fill the ventricular cavity of the intact formalin-fixed heart ( fig. 1) .
A left ventricular hypertrophy/dilatation index was computed from the ratio of average left ventricular wall thickness divided by the maximal left ventricular diameter. The indexes of short-term and long-term survivors of idiopathic dilated congestive cardiomyopathy were compared with indexes of 10 autopsied patients with no cardiac pathology (normal subjects) and 10 patients with compensated volume overload secondary to aortic or mitral valvular regurgitation.
Differences between the two groups of patients with cardiomyopathy were tested for significance using the unpaired t test. An analysis of variance was used to compare the hypertrophy/dilatation indexes of the two groups of cardiomyopathy with the volume overload and normal groups.
Results

Clinical Findings
The clinical data of the short-term and long-term survivors are shown in table 1. There were 15 patients in each group. The interval from first symptom of cardiac dysfunction until death in the short-term survivors ranged from 3 weeks to 1 1 months (average 6 months), and in the long-term survivors, from 1 year to 14 years (average 72 months). Not surprisingly, the long-term survivors were older. There were no significant differences between the two groups in regard to vivors (540 ± 134 g) (p < 0.001). The average left ventricular wall was thicker in the long-term patients (1.3 ± 0.18 cm) than in the short-term patients (1.0 ± 0.17 cm) (p < 0.005). This difference in extent of left ventricular hypertrophy could not be accounted for by differences in extent of cavity dilatation. The maximal left ventricular diameter was 6.3 ± 1.3 cm in shortterm survivors and 6.4 ± 1.1 cm in long-term survivors (NS). The left ventricular volume was also similar for both groups, 152 ± 79 ml for the shortterm survivors and 161 ± 74 ml for the long-term survivors ( figs. 1 and 2) .
A left ventricular hypertrophy-dilatation index (average left ventricular wall thickness/maximal left ventricular cavity diameter) was calculated for the short-term and long-term survivors. The index was compared with the same index obtained from the hearts of the patients with no evidence of cardiac disease and the 10 autopsied patients with volume overload due to long-standing valvular regurgitation. 444 CIRCULATION To study the relationship between length of survival and the ratio of left ventricular wall thickness to left ventricular diameter, the patients were divided into two groups: those with a thickness/diameter ratio > 0.2 (n = 9) and those with a ratio < 0.2 (n = 20). Lifetable analysis ( fig. 3) was performed, and patients with a thickness/diameter ratio > 0.2 survived longer (Z = 2.078, p = 0.02). In contrast, when the patients were divided into those with a left ventricular diameter greater than 6.0 cm and those with a left ventricular diameter less than 6.0 cm, there was no difference in the survival as determined by life-table analysis (Z = 0.66, p = 0.3) (fig. 4) .
Discussion
Morphologic studies often emphasize the significance of cavity dilatation in patients with congestive cardiomyopathy, and have not focused on the wide spectrum of cardiac hypertrophy that may occur. Some clinical studies, however, have suggested that in congestive cardiomyopathy, the development of left ventricular hypertrophy may be an important factor in survival. At least two cardiac catheterization studies have shown that in patients with congestive cardiomyopathy, thick left ventricular walls and a large myocardial mass carry a more favorable prognosis,2' 5 although the inability to definitely exclude patients with myocarditis and secondary forms of congestive cardiomyopathy has been limiting. In autopsy studies, one can define the myocardiopathy and precisely and uniformly measure cardiac mass and wall thickness.
In the autopsy data presented here, idiopathic dilated congestive cardiomyopathy was characterized by cavity dilatation, but the clinical course was more closely related to left ventricular hypertrophy, with extent of hypertrophy rather than the severity of dilatation linked to survival. In these patients we could not differentiate short-term (less than 1 year after first symptom) from long-term (more than 1 year) survivors on the basis of clinical history, physical examination, chest radiograph or ECG alone. Although electrocardiographic left ventricular hypertrophy is a specific but rather insensitive predictor of survival in patients with congestive cardiomyopathy,7 only three (10%) of our patients had left ventricular hypertrophy by ECG. In fact, these three patients had lighter hearts (463 ± 57 g) than the 27 patients without electrocardiographic left ventricular hypertrophy (660 + 161 g) (p < 0.05). The poor sensitivity of the ECG in FIGURE 2. A heart from a short-term survivor with idiopathic congestive cardiomyopathy. The postmortem angiogram (A) and transverse section through the ventricles (B) show that this heart has a wall which is thinner than would be expected for cavity size, thinner than the walls of the heart in figure 1 . This patient survived 12 months after his first symptom of heart failure. 
Clinical Implications
The findings of this study suggest that patients with idiopathic congestive cardiomyopathy in whom compensatory hypertrophy has occurred, or is developing, should have a more favorable prognosis. The clinical evaluation of these patients using one-dimensional echocardiography or cardiac catheterization might permit the early classification of high-risk and lowrisk groups. Natural history studies, mindful of these subsets, might allow further differentiation of the cardiomyopathies into etiologic and, possibly, therapeutic subgroups. Das and Randall' reported that the finding of a thick (> 1.2 cm) left ventricular wall by one-dimensional echocardiogram predicts a favorable response to chronic vasodilator therapy. Thus, in patients with idiopathic dilated congestive cardiomyopathy, cardiac function, survival and response to therapy may be predicted by extent of hypertrophy. In the clinical and pathologic evaluation of idiopathic dilated congestive cardiomyopathy, it may be useful to recognize the subsets identified by extent of hypertrophy, as they not only point out a different clinical course but also may reflect differing pathophysiology.
